Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / India and its Diagnostic Influence
Oncology Precision medicine Digital and computational pathology Digital Pathology Workforce Trends Molecular Pathology Voices in the Community Omics Opinion and Personal Narratives Laboratory management

India, and its Diagnostic Influence

Kunal Sharma explains how digital pathology, genomics, and integrated diagnostics are reshaping cancer care across India and beyond

By Helen Bristow 06/03/2026 Interview 6 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders
  • Topic Commentary

Share

4 Topic Commentaries

India, and its Diagnostic Influence

India, and its Diagnostic Influence

  • Krishan Lal
    Krishan Lal, M.Sc., Ph.D.

    Physics/Materials Science; Science leadership

    •

    Indian National Science Academy

    The diagnosis of TB is no longer a death warrant,

    Source
  • Prakash N. Tandon
    Prakash N. Tandon, M.B.B.S., M.S.

    Neurosurgery

    •

    Indian National Science Academy

    The lack of quick, accurate, and inexpensive tests for drug-resistant TB hampers treatment,

    Source
  • David Dowdy
    David Dowdy, MD, PhD

    Infectious Disease Epidemiology

    •

    Johns Hopkins Bloomberg School of Public Health

    Microscopic analysis of sputum for TB is cheap and widely available, but misses half of all TB cases,

    Source
  • Madhukar Pai
    Madhukar Pai, MD, PhD

    Global Health; Tuberculosis Diagnostics

    •

    McGill University

    “Unfortunately, we still do not have an accurate point-of-care test for TB, as we have for infections like HIV or malaria. The WHO policy strongly encourages future research to develop novel or improved serological tests,”

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Helping Hand from AI in Prostate Cancer Diagnostics
Precision medicine
A Helping Hand from AI in Prostate Cancer Diagnostics

February 8, 2022

3 min read

Using AI to enhance personalized healthcare for patients with prostate cancer

The Ultimate Vision for Rare Disease
Precision medicine
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational pathology can take rare disease diagnostics to the next level

A Light in the Darkness
Precision medicine
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

In-House Matters
Precision medicine
In-House Matters

April 7, 2022

3 min read

Molecular pathology is complex – and the benefits of keeping it local are extensive

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.